Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice . Individuals with a heterozygous mutation at the ataxia-telangiectasia mutated gene ( Q13315 ) have been reported to be predisposed to ischemic heart disease . This report examined for the first time the effect of a heterozygous Q13315 mutation ( Q13315 (+)(/-) ) on plasma lipid levels and atherosclerosis intensity using Q13315 (+/-) , Q13315 (+)(/+) ( wild type ) , Q13315 (+)(/+)/ P01130 (-)(/-) ( low density lipoprotein receptor knockout ) , Q13315 (+)(/-)/ P01130 (-)(/-) , Q13315 (+)(/+)/ApoE(-)(/-) ( apolipoprotein E knockout ) , and Q13315 (+)(/-)/ApoE(-)(/-) mice . Our data demonstrated that the plasma cholesterol and triglyceride levels in Q13315 (+)(/-) and Q13315 (+)(/-)/ P01130 (-)(/-) mice were approximately the same as those in Q13315 (+)(/+) and Q13315 (+)(/+)/ P01130 (-)(/-) control mice , respectively . In contrast , the plasma cholesterol level was significantly higher in Q13315 (+)(/-)/ApoE(-)(/-) mice than in Q13315 (+)(/+)/ApoE(-)(/-) control mice . In addition , the Q13315 (+)(/-)/ApoE(-)(/-) mice showed higher plasma apoB-48 levels , slower clearance for plasma apoB-48-carrying lipoproteins , and more advanced atherosclerotic lesions in the aorta compared with the Q13315 (+)(/+)/ApoE(-)(/-) mice . These novel results suggest that the product of Q13315 is involved in an apoE-independent pathway for catabolism of apoB-48-carrying remnants ; therefore , superimposition of a heterozygous Q13315 mutation onto an ApoE deficiency background reduces the clearance of apoB-48-carrying lipoproteins from the blood circulation and promotes the formation of atherosclerosis .